Diaceutics Statements
DX
Diaceutics Income Statement
B
M
GBP (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
13.775
100
2.769
20.1
11.006
79.9
—
0
11.911
86.5
11.858
86.1
-0.852
-6.2
0.369
2.7
—
0
-0.483
-3.5
-0.222
-1.6
-0.261
-1.9
-0.003
83.981
9.924
100
1.224
12.3
8.7
87.7
—
0
10.873
109.6
10.866
109.5
-2.166
-21.8
0.211
2.1
—
0
-1.955
-19.7
-0.47
-4.7
-1.485
-15
-0.018
84.472
11.976
100
0.349
2.9
11.627
97.1
—
0
10.007
83.6
9.989
83.4
1.638
13.7
0.057
0.5
—
0
1.695
14.2
0.204
1.7
1.491
12.4
0.017
88.07
7.528
100
2.414
32.1
5.114
67.9
—
0
6.273
83.3
6.177
82.1
-1.063
-14.1
-0.068
-0.9
—
0
-1.131
-15.02
-0.364
-4.8
-0.767
-10.2
-0.009
84.109
7.977
100
0.131
1.6
7.846
98.4
—
0
6.816
85.4
6.765
84.8
1.081
13.6
-0.082
-1.03
—
0
0.999
12.5
0.103
1.3
0.896
11.2
0.01
85.815
5.966
100
1.58
26.5
4.386
73.5
—
0
5.061
84.8
4.917
82.4
-0.531
-8.9
-0.006
-0.1
—
0
-0.537
-9.001
-0.202
-3.4
-0.335
-5.6
-0.004
84.069
7.395
100
1.688
22.8
5.707
77.2
—
0
6.189
83.7
6.009
81.3
-0.301
-4.08
-0.019
-0.3
—
0
-0.708
-9.6
0.105
1.4
-0.814
-11.001
-0.01
84.069
5.301
100
1.545
29.1
3.756
70.9
—
0
3.826
72.2
3.724
70.3
0.031
0.6
-0.005
-0.1
—
0
0.026
0.5
-1.05
-19.8
1.077
20.3
0.015
71.173
9.072
100
1.864
20.6
7.207
79.4
—
0
4.883
53.8
4.783
52.7
2.424
26.7
-0.02
-0.2
—
0
2.466
27.2
0.336
3.7
2.131
23.5
0.031
69.782
4.371
100
1.267
29
3.104
71
—
0
3.505
80.2
3.439
78.7
-0.336
-7.7
-0.223
-5.09
—
0
-1.969
-45.05
-0.236
-5.4
-1.733
-39.6
-0.03
58.557